Home | Cancers | Lung Cancer

Lung Cancer

Immune Cells Recruited to Support Lung Cancer Growth Could Offer New Drug Targets

Lung cancers attract circulating immune cells to the tumor mass, where the cancer reprograms them to support its growth and progression, researchers ...

Women’s lung cancer cases hit 20,000

Cases of lung cancer in women have reached 20,000 a year in the UK for the first time since records began, according ...

Comorbid Conditions Associated With Worse Lung Cancer Survival

PHILADELPHIA — Lung cancer patients with comorbid conditions such as chronic obstructive pulmonary disease, diabetes, or congestive heart failure had a higher risk of death than lung cancer patients without comorbid conditions, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. ... Full story

Comorbid conditions hurt lung cancer survival rates

by Lauren Riley, American Association for Cancer Research and Tom O'Connor, UNMC public relations ... Full story

Wistar Scientists Discover “Highly Effective” New Biomarker for Lung Cancer

PHILADELPHIA—(June 3, 2015)—Survival rates for patients with lung cancer increase dramatically the earlier the disease is diagnosed, underscoring the need for effective biomarkers that can be used for detection. Now, scientists at The Wistar Institute have found a protein that circulates in the blood that appears to be more accurate at detecting non-small cell lung cancer (NSCLC) than currently available methods used for screening. ... Full story

Moffitt Cancer Center Researchers Report that MEDI4736 Combined with Tremelimumab Results in Acceptable Toxicity, Clinical Activity in Non-Small Cell Lung Cancer Patients

TAMPA, Fla. – Advanced non-small cell lung cancer (NSCLC) patients have few effective treatment options and low 5-year survival rates. ... Full story

Molecule Designed to Treat Lung Cancer Shows Promising Results in Mice

A multidisciplinary team led by Johns Hopkins researcher Venu Raman, Ph.D., with notable contributions from Guus Bol, Farhad Vesuna and Phuoc Tran of Johns Hopkins, has identified a new therapy for lung cancer, the most common cancer worldwide. ... Full story

Drug-resistant lung cancer may have Achilles heel

By Bill Hathaway - Drugs introduced more than a decade ago that target mutations in a protein known as the epidermal growth factor receptor (EGFR) held the promise of personalized treatments for a common form of non-small cell lung cancer. But most patients quickly develop resistance to these drugs and are left with few or no treatment options, because it has been very difficult to design new drugs that act selectively upon the drug-resistant form. ... Full story

Stereotactic Ablative Radiotherapy achieves better overall survival than surgery for early lung cancer

First randomized clinical trial comparing the two therapies suggests that the non-invasive SABR treatment should be considered an alternative to surgery, especially for elderly patients and those with comorbidities ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 151 | displaying: 1 - 10